Schott Pharma AG & CO KGaA Revenue Growth & History (1SXP)
Schott Pharma AG & CO KGaA reported €986.2M in revenue for fiscal 2025, an increase of 3.04% from the previous fiscal year.
View full Schott Pharma AG & CO KGaA company overviewSchott Pharma AG & CO KGaA annual revenue and growth
2020
2021
2022
2023
2024
2025
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | €986.2M | €29.1M | +3.04% |
| 2024 | 2024-09-30 | €957.1M | €58.5M | +6.51% |
| 2023 | 2023-09-30 | €898.6M | €77.5M | +9.43% |
| 2022 | 2022-09-30 | €821.1M | €172.5M | +26.59% |
| 2021 | 2021-09-30 | €648.7M | €64.4M | +11.03% |
| 2020 | 2020-09-30 | €584.2M | — | — |
Schott Pharma AG & CO KGaA quarterly revenue
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q3 2026 | 2026-06-30 | €281.8M | €25.6M | +9.99% |
| Q2 2026 | 2026-03-31 | €247.9M | −€3.8M | −1.51% |
| Q1 2026 | 2025-12-31 | €240.2M | — | — |
| Q4 2025 | 2025-09-30 | €247.6M | — | — |
| Q3 2025 | 2025-06-30 | €256.2M | — | — |
| Q2 2025 | 2025-03-31 | €251.7M | — | — |
Schott Pharma AG & CO KGaA revenue growth trends
Over the last five reported fiscal years, revenue grew from €584.2M to €986.2M, a compound annual growth rate of 11.04%. Schott Pharma AG & CO KGaA's latest reported quarter, Q3 2026, generated €281.8M in revenue, an increase of 9.99% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Schott Pharma AG & CO KGaA source filings ↗